Attentional Re-training for Chronic Pain Patients

NCT ID: NCT04150419

Last Updated: 2022-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-15

Study Completion Date

2022-12-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hyper-vigilance, focusing, avoidance are part of the vocabulary used by the clinician who deals with chronic pain. These notions refer to the functioning and dysfunction of so-called "selective" attention. These "selective attentional biases" are believed to be responsible, in part, for the development and maintenance of negative pain-related thoughts (such as catastrophic thoughts), inappropriate behaviours (such as inactivity and fear of movement) and unpleasant emotions (such as stress or anger). In addition, they would also be a powerful indicator of the onset of post-operative pain and could limit the effectiveness of therapeutic management. Therapeutically, attention bias can be "managed" through attentional re-training techniques (ABMs) that teach patients to direct their attention differently. These techniques have been widely validated in anxious or addictive populations but have never been used to date in chronic pain patients. This home-based attention bias management (e-retraining) would represent, for chronic pain patients, an additional tool aimed not only at reducing their pain but also at achieving other associated factors such as anxiety, stress, catastrophic thoughts, avoidance behaviours and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After obtaining the patients' agreement, they will be randomized in one of the 3 experimental groups:

* G1: Attentional training to avoid threatening, negative or pain-related information.
* G2: Attention training for vigilance for positive emotional information.
* G3: neutral attentional training (control group).

The study will be conducted from the patient's home via a connection to the protected site of the Nantes University Hospital. The various questionnaires will be completed from the secure site of the Nantes University Hospital and the computerized experimental tasks will be carried out using the Inquisit software (WEB version at home).

The study will begin with an evaluation of the patients' attention and psychological processes (completion of questionnaires + 2 attention tasks), during a follow-up visit to the urology department of the University Hospital of Nantes.

Then, an 8-week attentional re-training program (2 training sessions per week) will be proposed.

At the end of the 8 weeks, an evaluation (Questionnaires + attention tasks) will be offered to patients always from home.

Finally, a final evaluation, 4 weeks after the end of the re-training, will always be proposed from the patient's home.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pelvic Perinal Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Attentional bias modification training chronic pelvi-perinal pain.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

G1

Group Type EXPERIMENTAL

Group 1

Intervention Type OTHER

Attentional training to avoid threatening, negative or pain-related information.

G2

Group Type EXPERIMENTAL

Group 2

Intervention Type OTHER

Attention training for vigilance for positive emotional information.

G3

Group Type ACTIVE_COMPARATOR

Group 3 (control group)

Intervention Type OTHER

Neutral attentional training (control group).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group 1

Attentional training to avoid threatening, negative or pain-related information.

Intervention Type OTHER

Group 2

Attention training for vigilance for positive emotional information.

Intervention Type OTHER

Group 3 (control group)

Neutral attentional training (control group).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic pain patients, i.e., chronic pain that has been ongoing for more than 3 months.
* Patient follow-up in the urology department of the University Hospital of Nantes
* Age between 18 and 65
* Good understanding of French, able to read and write.
* Serve correctly and painlessly with both hands
* Affiliated with a social security system
* Signed consent
* With internet access.

Exclusion Criteria

* Current and unstable psychiatric (mood disorders, anxiety disorders) and addictive (substance use disorders, alcoholic or otherwise, excluding nicotine) disorders.
* Does not use both hands properly and painlessly
* Depression (BDI-II ≤18)
* Patient under guardianship, curatorship or judicial protection
* Pregnant or breastfeeding woman
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Apicil

OTHER

Sponsor Role collaborator

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Virginie Quistrebert-Davanne, PhD

Role: PRINCIPAL_INVESTIGATOR

Nantes University Hospital Nantes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Nantes

Nantes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC18_0361

Identifier Type: -

Identifier Source: org_study_id